MetLife Investment Management’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-47,055
Closed -$2.85M 2875
2024
Q3
$2.85M Sell
47,055
-1,213
-3% -$71.8K 0.02% 828
2024
Q2
$2.71M Buy
48,268
+5,970
+14% +$333K 0.02% 837
2024
Q1
$2.39M Sell
42,298
-1,451
-3% -$78.6K 0.02% 880
2023
Q4
$1.97M Sell
43,749
-829
-2% -$33.5K 0.01% 955
2023
Q3
$2.03M Sell
44,578
-1,122
-2% -$52.4K 0.02% 898
2023
Q2
$1.98M Sell
45,700
-3,025
-6% -$133K 0.01% 935
2023
Q1
$3.2M Sell
48,725
-519
-1% -$32.1K 0.02% 705
2022
Q4
$2.22M Sell
49,244
-403
-0.8% -$21.9K 0.02% 865
2022
Q3
$3.59M Sell
49,647
-678
-1% -$67.3K 0.03% 585
2022
Q2
$5.4M Sell
50,325
-13
-0% -$1.32K 0.04% 379
2022
Q1
$5.58M Buy
50,338
+12,517
+33% +$1.31M 0.04% 453
2021
Q4
$4.84M Sell
37,821
-651
-2% -$83.7K 0.04% 416
2021
Q3
$5.12M Sell
38,472
-1,020
-3% -$127K 0.05% 352
2021
Q2
$4.27M Sell
39,492
-1,072
-3% -$115K 0.04% 470
2021
Q1
$4.27M Buy
40,564
+567
+1% +$63.2K 0.04% 470
2020
Q4
$4.16M Sell
39,997
-1,619
-4% -$157K 0.04% 438
2020
Q3
$3.56M Sell
41,616
-54,973
-57% -$4.65M 0.04% 445
2020
Q2
$7.08M Buy
96,589
+7,758
+9% +$527K 0.08% 210
2020
Q1
$4.61M Buy
88,831
+4,848
+6% +$265K 0.06% 280
2019
Q4
$4.73M Sell
83,983
-948
-1% -$48.3K 0.05% 376
2019
Q3
$4.05M Sell
84,931
-1,399
-2% -$75.2K 0.04% 432
2019
Q2
$4.68M Sell
86,330
-2,443
-3% -$112K 0.05% 378
2019
Q1
$3.6M Buy
88,773
+132
+0.1% +$5.16K 0.04% 514
2018
Q4
$2.76M Sell
88,641
-55
-0.1% -$2.12K 0.03% 599
2018
Q3
$4.04M Buy
88,696
+4,874
+6% +$206K 0.04% 469
2018
Q2
$3.51M Sell
83,822
-59,983
-42% -$2.42M 0.04% 512
2018
Q1
$5.91M Sell
143,805
-864
-0.6% -$36.8K 0.07% 268
2017
Q4
$5.94M Buy
+144,669
New +$5.89M 0.07% 276

Other funds holding CTLT

MetLife Investment Management's CTLT Position: Q4 2024 in Review

MetLife Investment Management sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 47,055 shares — an estimated $2.85M sold.

MetLife Investment Management first reported a position in CTLT in Q4 2017 and held it in 28 quarters. The position peaked at $7.08M in Q2 2020. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.

  • MetLife Investment Management reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
  • MetLife Investment Management sold 47,055 CATALENT, INC. shares in Q4 2024, an estimated $2.85M.
  • MetLife Investment Management first reported a position in CATALENT, INC. in Q4 2017 and held it in 28 quarters.
  • MetLife Investment Management's CATALENT, INC. position peaked at $7.08M in Q2 2020.
  • 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.